Rheumatic heart disease in Indigenous young peoples.


Journal

The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925

Informations de publication

Date de publication:
06 2021
Historique:
received: 02 07 2020
revised: 06 09 2020
accepted: 16 09 2020
pubmed: 12 3 2021
medline: 27 7 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

Indigenous children and young peoples live with an inequitable burden of acute rheumatic fever and rheumatic heart disease. In this Review, we focus on the epidemiological burden and lived experience of these conditions for Indigenous young peoples in Australia, New Zealand, and Canada. We outline the direct and indirect drivers of rheumatic heart disease risk and their mitigation. Specifically, we identify the opportunities and limitations of predominantly biomedical approaches to the primary, secondary, and tertiary prevention of disease among Indigenous peoples. We explain why these biomedical approaches must be coupled with decolonising approaches to address the underlying cause of disease. Initiatives underway to reduce acute rheumatic fever and rheumatic heart disease in Australia, New Zealand, and Canada are reviewed to identify how an Indigenous rights-based approach could contribute to elimination of rheumatic heart disease and global disease control goals.

Identifiants

pubmed: 33705693
pii: S2352-4642(20)30308-4
doi: 10.1016/S2352-4642(20)30308-4
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-446

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Rosemary Wyber (R)

The George Institute for Global Health, Newtown, NSW, Australia. Electronic address: rosemary.wyber@telethonkids.org.au.

Vicki Wade (V)

RHDAustralia, Menzies School of Health Research, Darwin, NT, Australia.

Anneka Anderson (A)

Tomaiora Research Group, University of Auckland, Auckland, New Zealand.

Yoko Schreiber (Y)

Section of Infectious Diseases, University of Manitoba, Clinical Sciences Division, Northern Ontario School of Medicine, ON, Canada.

Raphael Saginur (R)

Ottawa Hospital Research Institute, ON, Canada.

Alex Brown (A)

South Australian Health and Medical Research Institute, University of Adelaide, SA, Australia.

Jonathan Carapetis (J)

Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Perth, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH